Skip to main content

FibroGen, Inc. (NASDAQ: FGEN) Investor Securities Class Action Lawsuit 04/12/2021

  • If you purchased shares of FibroGen, Inc. (NASDAQ: FGEN), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

December 7, 2023 - The parties entered into a stipulation of settlement. October 3, 2023 - The court issued an order granting in part the motion for class certification. The order was filed under seal. January 27, 2023 - A motion was filed for class certification. July 15, 2022 - The court issued an order denying motion to dismiss. January 14, 2022 - A motion was filed to dismiss the ...



You must register (for free) or login to view the entire case.